NHI-2
Product Specifications
CAS Number
1269802-97-2
Target
Apoptosis, Dehydrogenase
Related Pathways
Apoptosis, Metabolism
Purity
0.99981
Bioactivity
NHI-2 is a lactate dehydrogenase A (LDHA) inhibitor with an IC50 value of 14.7 μM, demonstrating high selectivity for LDHA over LDHB, for which the IC50 is 55.8 μM. NHI-2 functions as an efficient anti-glycolytic agent, enhancing apoptosis, inducing cell cycle arrest at the S and G2 phases, and exerting broad-spectrum antiproliferative effects in cancer cells. NHI-2 additionally affects extracellular acidification rates and ATP production and has demonstrated tumor growth suppression in murine B78 melanoma models, highlighting its role in cancer metabolism research.
Smiles
C(F)(F)(F)C1=C2C(N(O)C(C(OC)=O)=C2)=CC(=C1)C3=CC=CC=C3
Molecular Formula
C17H12F3NO3
Molecular Weight
335.28
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6496372-01 0.1 mL
RAB7B (Ras-related Protein Rab-7b) (MaxLight 650)
Sign In for Pricing
View Details MBS6496372-02 5x 0.1 mL
RAB7B (Ras-related Protein Rab-7b) (MaxLight 650)
Sign In for Pricing
View Details